MCM
REGN icon

MV Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

MV Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38K Sell
61
-15
-20% -$10.2K ﹤0.01% 372
2026
Q1 		$58.7K Sell
76
-2
-3% -$1.53K 0.01% 302
2025
Q4 		$60.2K Buy
78
+16
+26% +$10.9K 0.01% 294
2025
Q3 		$34.9K Buy
62
+22
+55% +$12.4K ﹤0.01% 362
2025
Q2 		$21K Sell
40
-35
-47% -$19.5K ﹤0.01% 434
2025
Q1 		$47.6K Sell
75
-5
-6% -$3.44K 0.01% 309
2024
Q4 		$57K Sell
80
-7
-8% -$5.88K 0.01% 283
2024
Q3 		$91.5K Buy
87
+1
+1% +$1.11K 0.01% 244
2024
Q2 		$90.4K Buy
86
+7
+9% +$6.79K 0.01% 240
2024
Q1 		$76K Sell
79
-4
-5% -$3.8K 0.01% 260
2023
Q4 		$72.9K Buy
83
+8
+11% +$6.59K 0.01% 260
2023
Q3 		$61.7K Buy
75
+5
+7% +$3.93K 0.01% 267
2023
Q2 		$50.3K Hold
70
– – 0.01% 295
2023
Q1 		$57.5K Buy
70
+8
+13% +$6.03K 0.01% 263
2022
Q4 		$44.7K Buy
62
+3
+5% +$2.21K 0.01% 237
2022
Q3 		$41K Buy
59
+7
+13% +$4.41K 0.01% 241
2022
Q2 		$31K Buy
52
+16
+44% +$10.4K 0.01% 270
2022
Q1 		$25K Buy
36
+4
+13% +$2.53K ﹤0.01% 307
2021
Q4 		$20K Sell
32
-2
-6% -$1.23K ﹤0.01% 325
2021
Q3 		$21K Buy
34
+14
+70% +$8.69K ﹤0.01% 306
2021
Q2 		$11K Buy
20
+17
+567% +$8.61K ﹤0.01% 355
2021
Q1 		$1K Buy
+3
New +$1.46K ﹤0.01% 421

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

MV Capital Management's REGN Position: Q2 2026 in Review

MV Capital Management reduced its Regeneron Pharmaceuticals (REGN) stake by 20% in Q2 2026, selling an estimated $10.2K and leaving 61 shares worth $38K. The position accounts for ﹤0.01% of the portfolio, ranked #372.

MV Capital Management first reported a position in REGN in Q1 2021 and has held it in 22 quarters since. The position peaked at $91.5K in Q3 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • MV Capital Management held 61 shares of Regeneron Pharmaceuticals worth $38K as of Q2 2026.
  • MV Capital Management sold 15 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $10.2K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of MV Capital Management's portfolio in Q2 2026, its #372 holding.
  • MV Capital Management first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • MV Capital Management's Regeneron Pharmaceuticals position peaked at $91.5K in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.